Results 101 to 110 of about 44,802 (314)

Burden and Risk Factors of CGM‐Detected Hypoglycemia in Older Adults With Type 2 Diabetes

open access: yesJournal of the American Geriatrics Society, EarlyView.
Among older adults with diabetes using insulin or sulfonylureas, the median time spent in hypoglycemia was 3.4% and ~66% of participants exceeded the target of < 1% time with CGM glucose < 70 mg/dL. ABSTRACT Background Comprehensive data on the burden of biochemical hypoglycemia in older adults with type 2 diabetes are lacking.
Michael Fang   +6 more
wiley   +1 more source

Effect of Obesity on the Use of Antiarrhythmics in Adults With Atrial Fibrillation: A Review

open access: yes
Effect of Obesity on the Use of Antiarrhythmics in Adults With Atrial Fibrillation: A ...
Rochelle Wynne (13091535)   +5 more
core  

Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts

open access: yes, 2002
The Langendorff-perfused rat heart with regional ischemia is increasingly used for evaluating drugs for prevention of phase-1, ischemia-induced ventricular fibrillation (VF).
Farkas, A, Curtis, M J; id_orcid
core   +1 more source

Amiodarone‐related thyroid dysfunction and associated outcomes in patients with heart failure—A nationwide cohort study

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Aim Amiodarone increases the risk of thyroid dysfunction, but the prognostic significance of this complication in patients with heart failure (HF) is uncertain. This study investigates the association between amiodarone‐related thyroid dysfunction and risk of HF hospitalization or death in a nationwide cohort.
Søren Lund Kristensen   +11 more
wiley   +1 more source

PULSE PRESSURE CLASSES AND DOSAGE OF THE MAIN GROUPS OF CARDIAC MEDICATIONS IN PATIENTS AT THE ANNUAL FOLLOW-UP PERIOD AFTER PACING

open access: yesJournal of V. N. Karazin Kharkiv National University: Series Medicine, 2017
Dose factor of the main groups of cardiac medications in five pulse pressure (PP) classes was studied in 220 patients (110 men and 110 women) at the annual stage after pacing, the average age 70 ± 9 years.
Pochinska M. V., Shevchuk M. I.
doaj  

Pre‐anaesthetic risk assessment and management of dogs with myxomatous mitral valve disease: a spectrum of care narrative review

open access: yesJournal of Small Animal Practice, EarlyView.
Myxomatous mitral valve disease, an acquired valvular degeneration, is the most common cardiac disorder in dogs, affecting approximately 10% of dogs in primary care veterinary practice. Dogs with myxomatous mitral valve disease frequently require anaesthesia for routine procedures.
I. Levinzon   +3 more
wiley   +1 more source

Modified Anatomical Ablation Strategy for Mitral Isthmus

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Durable mitral isthmus (MI) block remains challenging in persistent atrial fibrillation (AF) ablation. Ethanol infusion into the vein of Marshall (EI‐VOM) enhances efficacy, but the minimal endocardial ablation extent post‐EI‐VOM is undefined.
Kui He   +7 more
wiley   +1 more source

Antiarrhythmic drugs [PDF]

open access: yesCanadian Anaesthetists’ Society Journal, 1986
openaire   +2 more sources

Pulmonary Vein Isolation in Elderly Patients With Atrial Fibrillation and Symptomatic Sick Sinus Syndrome: A Case Series

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT In patients with atrial fibrillation (AF), sinus node disease (SND) represents a potentially reversible concomitant condition. Initial treatment with catheter ablation (CA) aimed at restoration of sinus rhythm may provide an alternative to pacemaker implantation. In this case series, 15 elderly patients (>65 years) with AF and SND underwent CA,
Cerine Benachi   +9 more
wiley   +1 more source

Incidence and Determinants of Implantable Cardioverter‐Defibrillator Therapy With Loss of and Impaired Consciousness

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Implantable cardioverter‐defibrillators (ICDs) are important in the prevention of sudden cardiac death. However, some appropriate ICD therapies may be considered unnecessary, delivered when patients do not experience symptoms of hemodynamic instability such as loss of consciousness.
Alwin B. P. Noordman   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy